Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep571 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Reasons of Liraglutide discontinuation in Tunisian type 2 diabetic patients

Chadia Zouaoui , Hadj Sliman Chayma Bel , Najla Bchir , Chanez Kalboussi , Eya Sassi , benchhida annam , Ouertani Haroun

Introduction: Liraglutide is an anti-diabetic drug that has been shown to be effective for glycemic control and weight loss. However, factors such as unavailability, high cost, and side effects may make it challenging for patients to continue treatment. Our study aims to identify these barriers to treatment adherence and to understand the factors contributing to the discontinuation of Liraglutide therapy in Tunisian patients with type 2 diabetes (T2D).Me...

ea0099ep1156 | Pituitary and Neuroendocrinology | ECE2024

Hyperprolactinemia: a rare association between primary hypothyroidism and macroprolactinoma

Sassi Eya , Chermiti Sondes , Zitoun Bochra , Marzouk Hajer , Kharrat Issam , Hasni Yosra , Debbabi Wided

Introduction: Primary hypothyroidism is a common cause of hyperprolactinemia. TSH measurement is part of the first-line investigation of hyperprolactinemia wich usually disappear after L-thyroxine therapy. the presence of pituitary hyperplasia mimicking a pituitary macroadenoma has been reported by several authors, but coexistence oh primary hypothyroidism and prolactinoma is rarely reported.Case: We report a rare case of hyperprolactinemia revealing the...